Polaryx Therapeutics, Inc.
PLYX· Nasdaq
Released Mar 23, 2026, after the close
10-K filed Mar 24, 2026, 83 days after period end · 0001213900-26-033064
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
no prior Q4 2024 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Polaryx Therapeutics, Inc. · CIK 2075320 · Engraved from SEC EDGAR
+16.7% from the close of Mar 23, 2026 to the close of Mar 24, 2026, the first after the release.